id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-1437-0005,FDA,FDA-2013-E-1437,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-29T02:25:17Z,,0,0,0900006481dd65b0
FDA-2013-E-1437-0004,FDA,FDA-2013-E-1437,"Determination of Regulatory Review Period for Purposes of Patent Extension: JETREA,",Notice,Determinations,2015-12-23T05:00:00Z,2015,12,2015-12-23T05:00:00Z,2016-02-23T04:59:59Z,2015-12-23T17:26:13Z,2015-32247,0,0,0900006481dcaddd